Performance vs S&P 500

03
Tracked Q1 2025–Q3 2025 +252.4%
S&P 500 total return (same window) +21.3%
Excess return +231.1%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

04
Healthcare 99.7%
Other/Unmapped 0.3%

Full portfolio 2 positions

05
Type Streak 8Q trend
STOK Stoke Therapeutics, Inc. - Common Stock $53,020,254 99.68% 2,256,181 $16,062,600 Down ×2
XBI SPDR SERIES TRUST $168,937 0.32% 1,686 $29,117

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
STOK Trimmed -1.0M +$16.1M
XBI Price move only +0 +$29K